This site gives you access to a set of useful materials that will remind you and your patients about the warnings and precautions relating to tofacitinib and appropriate actions to take.
Please confirm you are a healthcare professional
This page gives you access to a set of useful materials that will remind you and your patients about the warnings and precautions relating to XELJANZ (tofactinib citrate) and appropriate actions to take
This website belongs to Pfizer Hellas S.A.(“Pfizer”). Please read and review these Terms of Use carefully before accessing or using this website. By accessing or using this site, you acknowledge that you have read, understood and agreed to these Terms of Use. If you do not agree to the Terms of Use, you may not access or use the website. Pfizer may alter these Terms of Use from time to time, so you should periodically check these Terms of Use as any changes will take effect as soon as they are posted to this website.
Copyright © 2018 Malta, Pfizer Hellas S.A. All rights reserved.
Date of preparation: 02/2018
XELZ-MT-WEB, V1.0